Investments & digital assets › F8949.A.X68
F8949.A.X68 · federal · F8949 line A.X68
Delmar Pharma (acquired 2024-06-25, sold 2025-05-07; proceeds 507.31, basis 568.53)
-61.22
engine v3
not yet verified
How this number was built
R-8949-LOT One line per sale: proceeds minus basis plus adjustment. Broker basis is used as reported unless a supplemental statement for the same lot is matched.
Sources (6) — where the inputs came from
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 10 · field X68_desc · “Lot X68 description”
read as “Delmar Pharma” → Delmar Pharma
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 10 · field X68_acq · “Lot X68 date acquired”
read as “06/25/2024” → 2024-06-25
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 10 · field X68_sold · “Lot X68 date sold”
read as “05/07/2025” → 2025-05-07
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 10 · field X68_proceeds · “Lot X68 proceeds”
read as “507.31” → 507.31
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 10 · field X68_basis · “Lot X68 cost basis”
read as “568.53” → 568.53
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 10 · field X68_wash · “Lot X68 wash sale loss disallowed”
read as “0.00” → 0
99%
Flows into
History — nothing is overwritten
v1 · 2026-03-04: -61.22v2 · 2026-03-19: -61.22v3 · 2026-06-23: -61.22
Adjust this number
Evidence & discussion
Record how you verified it